{{Rsnum
|rsid=897959
|Gene=AKT3
|Chromosome=1
|position=243734472
|Orientation=plus
|GMAF=0.4564
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=AKT3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 41.6 | 51.3
| HCB | 32.8 | 45.3 | 21.9
| JPT | 31.0 | 51.3 | 17.7
| YRI | 98.0 | 2.0 | 0.0
| ASW | 56.1 | 38.6 | 5.3
| CHB | 32.8 | 45.3 | 21.9
| CHD | 30.3 | 53.2 | 16.5
| GIH | 23.8 | 52.5 | 23.8
| LWK | 94.5 | 5.5 | 0.0
| MEX | 10.5 | 50.9 | 38.6
| MKK | 70.5 | 28.8 | 0.6
| TSI | 10.8 | 51.0 | 38.2
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19346957
|Title=Gene prioritization based on biological plausibility over genome wide association studies renders new loci associated with type 2 diabetes.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}